Annual Report and Notice of AGM

1st May 2025 07:00

RNS Number : 9357G
Somero Enterprises Inc.
01 May 2025
 

 

1 May 2025

Somero Enterprises, Inc.

("Somero" or the "Company")

Annual Report and Notice of AGM

Somero Enterprises, Inc., the North American manufacturer of patented, Laser Screed® equipment that automates the process of spreading and leveling volumes of concrete for commercial flooring and other horizontal surfaces, is pleased to announce that, pursuant to AIM Rule 20, its Annual Report and Accounts for the Financial Year ending 31 December 2024 ("Annual Report") has today been posted to shareholders of record as at 22 April 2025, along with the Notice of Somero's Annual General Meeting. The Annual Report and Notice of AGM are viewable on the Company's website at https://investors.somero.com/.

The Annual General Meeting of the Company will be held at 9:00 a.m. local time on 18 June 2025, at 14530 Global Parkway, Fort Myers, Florida 33913 USA and via webcast. Anyone wishing to participate via webcast can register to do so via instructions to be found on the Company's website at https://investors.somero.com/.

 

For further information, please contact: 

Somero Enterprises, Inc.

www.somero.com

Tim Averkamp, CEO

+1 239 210 6500

Vincenzo LiCausi, CFO

 

Howard Hohmann, EVP Sales

 

 

 

Cavendish Capital Markets Ltd (NOMAD and Broker)

+44 (0)20 7220 0500

Matt Goode/Seamus Fricker/Trisyia Jamaludin (Corporate Finance)

 

Tim Redfern/Harriet Ward (Corporate Broking)

 

 

 

Alma Strategic Communications (Financial Communications Advisor)

[email protected]

David Ison

+44 (0)20 3405 0205

Rebecca Sanders-Hewett

 

Will Merison

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACSURVKRVWUSOAR